Recent Publications
- Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Abstract »
- Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study. Abstract »
- Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study. Abstract »
The purpose of BRASS
The purpose of the Brigham and Women’s Rheumatoid Arthritis Sequential Study (BRASS), under the direction of Dr. Nancy Shadick and Dr. Michael Weinblatt, is to determine how genes can be used to predict whether Rheumatoid Arthritis (RA) will be mild or severe and to better understand how individuals respond to different drug treatments.
BRASS has over 1000 people diagnosed with RA who are patients at the Brigham & Women’s Hospital and who are followed in the clinic annually and sent questionnaires at six month intervals over a 5 year time span. Additionally, BRASS provides investigators with access to subsets of data as well as methodological support.
